Applications of Anti-Cytomegalovirus T Cells for Cancer (Immuno)Therapy

por Britsch, Isabel, van Wijngaarden, Anne Paulien, Helfrich, Wijnand
Publicado 2023

Bispecific antibody approach for EGFR-directed blockade of the CD47-SIRPα “don’t eat me” immune checkpoint promotes neutrophil-mediated trogoptosis and enhances antigen cross-prese...

por Hendriks, Mark A. J. M., Ploeg, Emily M., Koopmans, Iris, Britsch, Isabel, Ke, Xiurong, Samplonius, Douwe F., Helfrich, Wijnand
Publicado 2020

Novel Fab-peptide-HLA-I fusion proteins for redirecting pre-existing anti-CMV T cell immunity to selective eliminate carcinoma cells

por Britsch, Isabel, van Wijngaarden, Anne P., Ke, Xiurong, Hendriks, Mark. A.J.M., Samplonius, Douwe F., Ploeg, Emily M., Helfrich, Wijnand
Publicado 2023

A Novel Bispecific Antibody for EpCAM-Directed Inhibition of the CD73/Adenosine Immune Checkpoint in Ovarian Cancer

por Ploeg, Emily Maria, Britsch, Isabel, van Wijngaarden, Anne Paulien, Ke, Xiurong, Hendriks, Mark Alexander Johannes Martinus, Samplonius, Douwe Freerk, Helfrich, Wijnand
Publicado 2023

Cancer cells under immune attack acquire CD47-mediated adaptive immune resistance independent of the myeloid CD47-SIRPα axis

por Hendriks, Mark A.J.M., Britsch, Isabel, Ke, Xiurong, van Wijngarden, Anne P., Samplonius, Douwe F., Ploeg, Emily M., Helfrich, Wijnand
Publicado 2021

Bispecific antibody CD73xEGFR more selectively inhibits the CD73/adenosine immune checkpoint on cancer cells and concurrently counteracts pro-oncogenic activities of CD73 and EGFR

por Ploeg, Emily Maria, Samplonius, Douwe Freerk, Xiong, Xiao, Ke, Xiurong, Hendriks, Mark Alexander Johannes Martinus, Britsch, Isabel, van Wijngaarden, Anne Paulien, Zhang, Hao, Helfrich, Wijnand
Publicado 2023